Cholesterol-modifying drugs in COVID-19. (2020)

First Author: Schmidt NM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/oxfimm/iqaa001

PubMed Identifier: 33047740

Publication URI: http://europepmc.org/abstract/MED/33047740

Type: Journal Article/Review

Volume: 1

Parent Publication: Oxford open immunology

Issue: 1

ISSN: 2633-6960